These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 19352132

  • 1. Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up.
    Clatworthy MR, Friend PJ, Calne RY, Rebello PR, Hale G, Waldmann H, Watson CJ.
    Transplantation; 2009 Apr 15; 87(7):1092-5. PubMed ID: 19352132
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of Campath-1H as induction therapy in renal transplantation: preliminary results.
    Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roohipour R, Carreno MR, Roth D, Ruiz P, Kupin W, Rosen A, Esquenazi V, Tzakis AG, Miller J.
    Transplantation; 2004 Aug 15; 78(3):426-33. PubMed ID: 15316372
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation: a case report.
    Jirasiritham S, Khunprakant R, Techawathanawanna N, Jirasiritham S, Mavichak V.
    Transplant Proc; 2010 Apr 15; 42(3):987-9. PubMed ID: 20430222
    [Abstract] [Full Text] [Related]

  • 6. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
    Watson CJ, Bradley JA, Friend PJ, Firth J, Taylor CJ, Bradley JR, Smith KG, Thiru S, Jamieson NV, Hale G, Waldmann H, Calne R.
    Am J Transplant; 2005 Jun 15; 5(6):1347-53. PubMed ID: 15888040
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation.
    Villanueva ME, Muñoz AS, Casasola CC, Africa JB, Danguilan RA, Ona ET.
    Transplant Proc; 2008 Sep 15; 40(7):2222-5. PubMed ID: 18790198
    [Abstract] [Full Text] [Related]

  • 11. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up.
    Muñoz AS, Cabanayan-Casasola CB, Danguilan RA, Padua FB, Ona ET.
    Transplant Proc; 2008 Sep 15; 40(7):2230-3. PubMed ID: 18790200
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of alemtuzumab (Campath-1H) as induction therapy in pediatric kidney transplantation.
    Ona ET, Danguilan RA, Africa J, Cabanayan-Casasola CB, Antonio ZL, Gutierrez-Marbella MA, dela Cruz R, Bumanglag N, Espedilla ME.
    Transplant Proc; 2008 Sep 27; 40(7):2226-9. PubMed ID: 18790199
    [Abstract] [Full Text] [Related]

  • 17. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.
    Sampaio MS, Kadiyala A, Gill J, Bunnapradist S.
    Transplantation; 2009 Oct 15; 88(7):904-10. PubMed ID: 19935462
    [Abstract] [Full Text] [Related]

  • 18. Alemtuzumab induction in deceased donor kidney transplantation.
    Shin M, Song SH, Kim JM, Kwon CH, Joh JW, Lee SK, Kim SJ.
    Transplant Proc; 2011 Oct 15; 43(6):2365-78. PubMed ID: 21839271
    [Abstract] [Full Text] [Related]

  • 19. Campath-1H use in pediatric renal transplantation.
    Bartosh SM, Knechtle SJ, Sollinger HW.
    Am J Transplant; 2005 Jun 15; 5(6):1569-73. PubMed ID: 15888071
    [Abstract] [Full Text] [Related]

  • 20. Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).
    Gallon L, Gagliardini E, Benigni A, Kaufman D, Waheed A, Noris M, Remuzzi G.
    Clin J Am Soc Nephrol; 2006 May 15; 1(3):539-45. PubMed ID: 17699257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.